small
embryoniclik
stem
cell
vsel
repres
popul
extrem
small
nonhematopoiet
pluripot
cell
neg
lineag
marker
express
mice
human
embryoniclik
characterist
includ
express
marker
pluripot
abil
give
rise
cellular
deriv
three
germlay
abil
form
embryoidlik
bodi
inde
quiescent
vsel
may
repres
remnant
epiblastderiv
cell
adult
organ
tissu
injuri
includ
acut
myocardi
infarct
mi
bone
marrowderiv
vsel
mobil
peripher
blood
home
damag
organ
given
abil
vsel
differenti
cardiomyocyt
endotheli
cell
abil
secret
variou
cardioprotect
growth
factorscytokin
vsel
may
serv
ideal
cellular
sourc
cardiac
repair
consist
transplant
vsel
acut
mi
improv
left
ventricular
lv
structur
function
benefit
remain
stabl
longterm
followup
although
mechan
remain
investig
effect
secret
factor
regener
cellular
constitu
stimul
endogen
stemprogenitor
may
play
combinatori
role
purpos
review
summar
current
evid
regard
biolog
featur
vsel
discuss
potenti
cellular
substrat
therapeut
cardiac
repair
antioxid
redox
signal
ure
past
decad
attent
biomed
research
increasingli
direct
stem
cell
potenti
mediat
effect
tissu
repair
injur
organ
although
variou
cell
type
use
repair
infarct
myocardium
cell
exhibit
multipot
pluripot
behavior
proven
especi
efficaci
regen
purpos
despit
pluripot
natur
therapeut
applic
embryon
stem
cell
esc
deriv
develop
blastocyst
somat
nuclear
transfer
limit
known
propens
form
tumor
ethic
issu
result
pluripot
stem
cell
adult
tissu
capabl
differenti
deriv
three
germ
layer
becom
major
focu
interest
regen
medicin
cell
may
potenti
fulfil
grow
need
reliabl
noncontroversi
resourc
stem
cell
effect
regen
therapi
human
initi
describ
bone
marrow
adult
mice
rare
popul
character
unusu
small
size
small
embryoniclik
stem
cell
vsel
pluripot
cell
sever
embryoniclik
featur
albeit
without
tumorigen
activ
past
sever
year
morpholog
genet
function
characterist
vsel
establish
extens
systemat
analys
bodi
work
indic
vsel
abl
differenti
cell
three
germ
layer
recruit
peripher
blood
tissu
injuri
includ
myocardi
infarct
mi
particip
repair
infarct
myocardium
purpos
review
summar
current
evid
regard
biolog
featur
therapeut
potenti
vsel
repair
infarct
myocardium
vsel
identifi
nonhematopoiet
compart
adult
murin
bone
marrow
bm
rare
popul
primit
cell
posit
stem
cell
neg
hematopoiet
lineag
marker
lin
panleukocyt
marker
lin
also
shown
purifi
vsel
fraction
consist
primit
cell
express
marker
characterist
multipl
tissu
includ
neuron
endotheli
cell
pancreat
cell
skelet
muscl
cell
cardiomyocyt
vsel
enrich
mrna
cardiacspecif
antigen
csx
acquir
cardiomyocyt
phenotyp
vitro
subsequ
analys
use
novel
imag
cytometri
imagestream
system
iss
techniqu
character
quantifi
morpholog
featur
vsel
relat
primit
stage
includ
small
size
cytoplasm
area
nuclear
cytoplasm
ratio
nc
iss
combin
classic
flow
cytometri
fluoresc
microscopi
one
platform
allow
visual
cell
suspens
flow
acquisit
highresolut
brightfield
darkfield
fluoresc
imag
well
statist
analysi
sever
morpholog
featur
cell
base
collect
imag
techniqu
allow
identif
object
small
lm
diamet
help
identif
small
vsel
multipl
tissu
use
iss
abl
describ
adult
tissu
first
time
presenc
cell
smaller
erythrocyt
small
lm
possess
normal
diploid
number
chromosom
high
nc
vsel
greater
primit
matur
cell
confirm
previou
transmiss
electron
microscop
tem
observ
indic
presenc
rel
larg
nuclei
surround
narrow
rim
cytoplasm
insid
cell
exist
rare
nonhematopoiet
stem
cell
commit
variou
nonhematopoiet
tissu
suggest
ratajczak
colleagu
sever
year
ago
identif
purif
cell
adult
murin
bm
human
specimen
appli
novel
criteria
assum
cell
mobil
migrat
area
tissu
injuri
thu
express
receptor
chemokin
b
express
marker
stem
cell
includ
mice
human
c
belong
nonhematopoiet
compart
express
antigen
like
exhibit
small
size
last
featur
predict
base
small
size
esc
present
inner
mass
develop
blastocyst
expect
pluripot
stem
cell
exist
hidden
adult
tissu
similar
small
appear
use
fluorescenceactiv
cell
sort
fac
isol
vsel
murin
bm
howev
standard
sort
protocol
exclud
event
smaller
lm
diamet
includ
cell
debri
erythrocyt
platelet
small
vsel
usual
exclud
sort
cell
popul
standard
sort
protocol
therefor
need
modifi
includ
object
small
lm
diamet
achiev
goal
use
mixtur
bead
predefin
size
set
sort
morpholog
gate
includ
nongranularlymphocytelik
cell
size
rang
lm
region
mostli
contain
cellular
debri
also
rare
nucleat
cell
event
small
object
analyz
hematopoiet
lineag
marker
lin
express
lincel
includ
analysi
among
lincel
could
subsequ
identifi
predomin
subfract
hspc
rare
vsel
found
vsel
compris
approxim
wherea
hspc
compris
total
bm
nucleat
cell
fig
human
cband
bmderiv
vsel
isol
fac
use
modifi
protocol
strongli
consid
cellular
size
includ
object
larger
lm
diamet
sort
human
vsel
gate
lincel
next
step
two
fraction
human
hspc
vsel
distinguish
among
lincel
respect
similar
strategi
may
effect
use
antigen
replac
either
marker
fig
although
sort
strategi
success
isol
pluripot
vsel
also
result
larg
quantiti
cellular
debri
small
size
rang
advent
imag
cytometri
iss
enabl
us
first
time
distinguish
nucleat
vsel
cellular
debri
quantifi
true
content
vsel
confirm
exist
sort
materi
moreov
murin
vsel
could
analyz
sever
morpholog
featur
human
cbderiv
vsel
includ
averag
size
lm
confirm
smaller
human
erythrocyt
lm
diamet
fig
thu
techniqu
current
one
major
tool
vsel
identif
differ
type
specimen
anim
human
believ
small
size
murin
human
vsel
preclud
discoveri
cell
earlier
today
protocol
vsel
identif
isol
well
describ
valid
may
use
current
avail
flowcytometri
equip
cell
isol
vsel
term
small
embryoniclik
stem
cell
base
observ
cell
express
sever
marker
associ
pluripot
state
includ
nanog
give
rise
cell
three
germ
layer
also
exhibit
sever
featur
embryon
cell
ultrastructur
level
consist
tem
analys
purifi
bmderiv
vsel
nuclei
indic
presenc
primit
form
openstructur
euchromatin
describ
featur
embryon
stem
cell
besid
express
pluripot
marker
murin
bmderiv
vsel
bare
express
marker
stem
cell
zubasurma
et
al
mesenchym
stemstrom
cell
msc
express
mhci
mhcii
antigen
make
cell
attract
substrat
transplant
featur
well
strong
adhes
capac
cell
suggest
close
relat
msc
compart
within
bone
marrow
recent
vivo
studi
publish
taichman
colleagu
suggest
vsel
may
pluripot
fraction
cell
atop
msc
compart
may
respons
multipot
capac
msc
data
may
discuss
well
context
previou
find
show
vsel
fulfil
criteria
pluripot
capabl
differenti
cell
three
germ
layer
includ
neuron
ectoderm
pancreat
cell
endoderm
cardiomyocyt
mesoderm
one
may
therefor
postul
vsel
potenti
give
rise
fraction
morematur
tissuecommit
msc
observ
fraction
bmderiv
msc
express
antigen
may
support
close
relat
vsel
cell
within
mesenchym
compart
interestingli
also
observ
vsel
cultur
presenc
feederlay
cell
support
hematopoiet
differenti
stem
cell
cell
line
give
rise
cobbleston
form
cell
resembl
longterm
repopul
hematopoiet
stem
cell
lthsc
vselderiv
lthsc
gave
rise
type
hematopoiet
coloni
vitro
also
capabl
fulli
reconstitut
hematopoiet
lineag
myeloabl
mice
lethal
gamma
irradi
vivo
evid
support
vsel
pluripot
stem
cell
like
serv
precursor
mesenchym
hematopoiet
compart
stem
progenitor
cell
futur
investig
elucid
complex
relat
vsel
welldescrib
popul
experiment
protocol
bmvsel
isol
murin
bm
total
nucleat
cell
tnc
harvest
murin
tibia
femur
lysi
red
blood
cell
rbc
ammonium
chlorid
follow
stain
hematopoiet
lineag
marker
lin
b
gate
strategi
murin
bmvsel
sort
fac
agranular
small
event
rang
lm
includ
gate
comparison
sizepredefin
bead
particl
standard
diamet
lm
bm
nucleat
cell
visual
dotplot
show
forwardscatt
fsc
versu
sidescatt
ssc
signal
relat
size
granular
complex
cell
respect
cell
region
analyz
lin
express
linev
includ
region
popul
region
subsequ
distinguish
base
express
lin
vsel
region
lin
hsc
region
percentag
repres
averag
content
cellular
subpopul
total
bm
nucleat
cell
see
illustr
color
reader
refer
web
version
articl
www
liebertonlinecomar
one
first
import
observ
vsel
ultrastructur
presenc
open
euchromatin
nuclei
signific
find
led
us
extens
studi
elucid
epigenet
statu
vsel
includ
chromatin
methyl
histon
modif
regul
express
sever
gene
relat
vsel
pluripot
prolifer
statu
somat
imprint
nanog
result
studi
shown
similar
esc
cell
line
freshli
isol
vsel
exhibit
hypomethyl
open
chromatin
structur
promot
lead
activ
transcript
gene
mainten
pluripot
moreov
result
report
shin
et
al
explain
fundament
concern
regard
quiescenc
vsel
lack
teratoma
format
blastocyst
complement
base
uniqu
dna
methyl
pattern
development
crucial
imprint
gene
furthermor
uniqu
genom
imprint
pattern
vsel
describ
studi
show
tendenc
erasur
patern
hypomethyl
gene
hypermethyl
matern
methyl
one
describ
although
patern
express
imprint
gene
enhanc
growth
embryo
matern
express
gene
inhibit
cell
prolifer
therefor
differ
observ
vsel
show
growthrepress
imprint
cell
describ
epigenet
characterist
vsel
lead
upregul
growthrepress
gene
repress
growthpromot
gene
may
explain
vsel
quiescent
statu
moreov
cbvsel
isol
total
popul
human
cb
nucleat
cell
tnc
harvest
lysi
red
blood
cell
rbc
ammonium
chlorid
tnc
stain
hematopoiet
lineag
marker
lin
well
one
follow
stem
cell
antigen
b
gate
strategi
human
cbvsel
sort
fac
event
larger
lm
includ
gate
comparison
sizepredefin
bead
particl
standard
diamet
lm
cbderiv
tnc
visual
dotplot
present
forwardscatt
fsc
versu
sidescatt
ssc
signal
cell
region
analyz
hematopoiet
lineag
marker
lin
linsubpopul
includ
region
subsequ
analyz
base
express
two
fraction
cell
distinguish
base
appear
lin
vsel
region
lin
cell
hsc
region
percentag
show
averag
content
cellular
subpopul
total
cb
nucleat
cell
see
illustr
color
reader
refer
web
version
articl
wwwliebertonlinecomar
zubasurma
et
al
describ
import
autocrin
growth
factor
promot
expans
sever
cell
type
contrast
regulatori
mrna
note
inhibit
cell
prolifer
chang
express
two
gene
may
respons
quiescent
statu
vsel
supposedli
bmresid
vsel
remnant
embryon
develop
eg
deriv
epiblast
resid
dormant
state
ectop
bm
nich
quiescent
statu
cell
could
potenti
result
nonphysiolog
locat
b
exposur
inhibitor
c
depriv
pivot
stimulatori
signal
perhap
import
limit
pluripot
erasur
somat
imprint
crucial
somat
imprint
gene
vsel
howev
activ
expos
appropri
activ
signal
eg
upregul
organtissu
injuri
oncogenesi
undergo
epigenet
chang
alter
methyl
statu
dna
acetyl
histon
final
may
reactiv
stimul
prolifer
proper
somat
imprint
reestablish
hypothesi
support
recent
observ
revert
pattern
imprint
gene
methyl
vsel
cocultur
cell
well
format
embryoidlik
bodi
elb
process
enlarg
pool
prolifer
vsel
abl
differenti
three
germ
layer
therefor
potenti
modul
mechan
control
genom
imprint
vsel
would
crucial
develop
morepow
strategi
expand
cell
unleash
regen
potenti
effici
clinic
applic
subsequ
initi
discoveri
vsel
bm
identifi
sca
lin
cell
phenotyp
resembl
vsel
adult
murin
organ
includ
brain
kidney
pancrea
muscl
gonad
interestingli
found
highest
number
small
nucleat
lin
brain
follow
kidney
skelet
muscl
pancrea
bone
marrow
cell
respect
biolog
role
vsel
organ
remain
elucid
futur
experi
potenti
presenc
similar
small
primit
cell
adult
organ
includ
bone
marrow
also
report
investig
howev
possibl
systemat
explor
cell
type
fulli
character
singlecel
level
also
establish
similar
bmderiv
vsel
lin
differ
organ
enrich
marker
pluripot
nanog
mrna
protein
level
moreov
establish
vsel
share
phenotyp
genet
similar
primordi
germ
cell
pgc
popul
epiblastderiv
cell
migrat
genit
ridg
gestat
give
rise
germlin
cell
importantli
vsel
share
similar
uniqu
methyl
pattern
pgc
respons
quiescent
statu
pgc
make
ineffect
blastocyst
complement
somat
nucleartransf
assay
mice
pgc
gradual
reprogram
eras
genom
imprint
migrat
genit
ridg
day
post
coitum
dpc
suspect
similar
genom
chang
may
take
place
migrat
vsel
similar
stage
embryon
develop
vigor
migratori
capac
vsel
express
gene
characterist
pgc
plap
mvh
stella
fragili
nobox
similar
pattern
genom
imprint
well
embryoniclik
featur
vsel
lead
us
hypothes
vsel
repres
remnant
popul
epiblastderiv
psc
deposit
differ
organ
development
migrat
earli
stage
embryogenesi
adulthood
cell
could
potenti
respons
cellular
turnov
restor
pool
progenitor
differ
organ
particip
endogen
tissu
repair
although
well
establish
neither
brain
heart
postmitot
organ
made
finit
number
matur
cell
data
provid
strong
evid
similar
organ
brain
heart
constantli
undergo
tissu
renew
reli
activ
progenitor
residu
stem
cell
thu
envis
vsel
top
hierarchi
progenitor
cell
organ
rare
quiescent
popul
pluripot
cell
adult
tissu
importantli
establish
murin
vsel
may
alreadi
detect
embryon
tissu
dpc
develop
indic
embryon
extraembryon
origin
use
transgen
model
mice
develop
circul
system
necessari
stem
cell
migrat
extraembryon
yolk
sac
embryon
tissu
confirm
vsel
contrast
hematopoiet
stemprogenitor
cell
hspc
migrat
extraembryon
tissu
alreadi
present
develop
embryo
dpc
vsel
also
found
rapidli
develop
fetal
liver
establish
vsel
leav
organ
along
hspc
migrat
develop
bone
marrow
tissu
dpc
fact
addit
bm
popul
stem
cell
express
marker
epiblast
cell
recent
describ
sever
nonhematopoiet
organ
epidermi
bronchial
epithelium
myocardium
pancrea
testi
dental
pulp
retina
amniot
fluid
morpholog
cell
size
vari
slightli
depend
tissueorgan
locat
howev
presenc
epiblast
marker
cell
gener
support
concept
development
deposit
epiblastderiv
cellsvsel
develop
organ
believ
vigor
process
cell
migrat
earli
stage
embryogenesi
creat
opportun
epiblastderiv
vsel
infiltr
remain
develop
organ
adulthood
similar
popul
small
cell
enrich
fraction
express
marker
human
pluripot
stem
cell
nanog
mrna
protein
level
identifi
human
specimen
includ
umbil
cord
blood
cb
bm
human
cb
previous
describ
sourc
variou
stemprimit
cell
may
potenti
contribut
endotheli
hepat
neural
myocardi
regener
transplant
tissu
injuri
although
uniqu
capabl
cbderiv
cell
initi
explain
transdedifferenti
plastic
cbderiv
hspc
sever
report
challeng
concept
plastic
transdedifferenti
hspc
moreov
grow
evid
indic
presenc
nonhematopoiet
primit
cell
cb
potenti
contribut
organtissu
regener
cb
also
report
contain
sever
pluripot
nonhematopoiet
stem
cell
popul
includ
unrestrict
somat
stem
cell
ussc
shown
human
cb
bone
marrow
also
harbor
primit
vsel
popul
may
identifi
purifi
base
express
antigen
lack
hematopoiet
lineag
marker
lin
lin
note
fraction
enrich
marker
pluripot
perhap
repres
suitabl
fraction
potenti
futur
clinic
applic
use
imag
cytometri
establish
cbderiv
vsel
coexpress
marker
repres
rarest
fraction
smallest
size
highest
nc
ratio
compar
fraction
coexpress
antigen
howev
also
observ
approxim
small
vsel
may
lost
standard
clinic
procedur
prepar
cb
unit
cryopreserv
storag
clinic
use
condit
fraction
hspc
may
recov
high
yield
postul
loss
vsel
clinicalprepar
procedur
well
centrifug
ficol
gradient
may
relat
small
size
high
densiti
vsel
predispos
cross
gradient
separ
media
potenti
signific
loss
vsel
consid
process
cb
bm
mobil
peripher
blood
unit
erythrocyt
volumedeplet
protocol
storag
vsel
character
cell
exhibit
mostli
quiescent
statu
freshli
isol
bmderiv
vsel
prolifer
presenc
wellknown
media
suitabl
expans
pluripot
stem
cell
includ
esc
induc
pluripot
stem
cell
time
vsel
highli
resist
sever
environment
condit
normal
lethal
stemprogenitor
cell
includ
high
dose
gammairradi
cgi
unpublish
observ
featur
vsel
confirm
uniqu
primit
statu
cell
howev
found
cultur
presenc
feederlay
myoblast
cell
line
vsel
begin
aggreg
prolifer
form
spheric
structur
resembl
elb
fig
importantli
cellular
cluster
stain
posit
placent
alkalin
phosphatas
palp
marker
esc
indic
true
embryon
characterist
zubasurma
et
al
cell
moreov
cell
deriv
elb
preserv
primit
characterist
vigor
differenti
deriv
three
germ
layer
includ
cardiomyocyt
vitro
exclud
possibl
cell
fusion
feederlay
subsequ
prolifer
vsel
isol
egfp
transgen
mice
confirm
elb
form
exclus
egfp
cell
exhibit
normal
diploid
dna
content
similar
sphere
also
form
vsel
isol
murin
fetal
liver
spleen
thymu
interestingli
format
elb
restrict
vsel
isol
younger
mice
elb
observ
vsel
isol
older
mice
older
year
moreov
also
observ
number
vsel
bm
decreas
increas
age
mice
agedepend
decreas
vsel
number
bm
capac
sphere
format
may
explain
moreeffici
regener
process
younger
individu
would
interest
identifi
gene
respons
tissu
distribut
expans
vsel
may
involv
determin
life
span
mammal
cocultur
system
repres
one
mechan
vsel
expans
experiment
transplant
applic
mention
earlier
vsel
may
also
success
expand
presenc
cell
applic
experiment
hematolog
abil
adult
stem
cell
repair
injur
dysfunct
myocardium
human
establish
howev
ideal
cell
type
therapi
sever
relat
variabl
evalu
ongo
clinic
trial
regard
vsel
offer
sever
major
advantag
current
avail
cellular
substrat
first
given
pluripot
natur
abil
differenti
cardiomyocyt
endotheli
cell
vsel
appear
particularli
well
suit
cellularreplac
therapi
second
express
variou
angiogen
protect
factor
vsel
render
suitabl
myocardi
repair
via
paracrin
action
third
unlik
current
avail
pluripot
cell
embryon
stem
cell
induc
pluripot
cell
vsel
form
tumor
extend
followup
final
vsel
isol
adult
tissu
use
autolog
vsel
circumv
reject
potenti
immunolog
consequ
consist
attribut
result
anim
model
infarct
repair
acut
mi
indic
transplant
vsel
abl
induc
cardiac
repair
improv
lv
structur
function
import
consider
regard
use
vsel
therapeut
purpos
mobil
cell
variou
patholog
state
phenomenon
signifi
vsel
natur
intend
repair
damag
tissu
recent
studi
report
first
time
pluripot
vsel
express
embryon
marker
mobil
earli
phase
acut
mi
mice
subject
ischemiareperfus
injuri
level
circul
lin
vsel
elev
h
ir
injuri
follow
decreas
level
observ
untreat
control
mice
day
studi
confirm
presenc
pluripot
vsel
peripher
blood
pb
mi
comprehens
approach
first
use
flow
cytometri
vsel
identifi
pb
typic
phenotyp
lin
second
greater
mrna
level
marker
pluripot
nanog
detect
quantit
rtpcr
final
use
confoc
microscopi
verifi
express
marker
pluripot
protein
level
vsel
control
popul
lin
hsc
regard
mobil
vsel
confirm
patient
acut
mi
first
time
human
wojakowski
et
al
report
circul
pluripot
vsel
earli
phase
h
acut
event
patient
stsegment
elev
mi
stemi
fig
interestingli
mobil
vsel
significantli
reduc
older
patient
older
year
diabet
comparison
younger
nondiabet
patient
anoth
studi
abdellatif
et
al
investig
kinet
mobil
vsel
pluripot
cell
stemi
patient
compar
nonstemi
patient
chronic
ischem
heart
diseas
angina
consist
previou
data
result
show
acut
ischem
event
provid
strongest
stimulu
vsel
mobil
occur
earli
postinfarct
phase
result
concord
sever
studi
report
mobil
variou
type
bmderiv
cell
acut
myocardi
ischem
injuri
includ
mobil
hematopoiet
stem
cell
mesenchym
stem
cell
endotheli
progenitor
cell
distinct
subpopul
character
surfac
marker
circul
progenitor
ckit
cmet
subpopul
observ
patient
acut
mi
studi
anim
also
shown
presenc
bmderiv
ckit
cell
infarct
myocardium
mi
progenitor
cell
detect
pb
patient
acut
mi
express
increas
level
mrna
earli
cardiac
endotheli
vecadherin
von
willebrand
factor
marker
similar
result
obtain
mice
howev
content
pluripot
cell
determin
express
marker
pluripot
mobil
cell
type
investig
studi
also
report
murin
bmderiv
vsel
mobil
gcsf
stimul
well
variou
form
tissu
injuri
includ
muscl
injuri
stroke
acut
mi
anim
model
patient
collect
data
suggest
teleolog
import
function
vsel
tissu
repair
injuri
believ
addit
comprehens
analysi
vsel
mobil
mi
anim
human
model
would
bring
us
closer
establish
time
window
endogen
mechan
heart
repair
highli
activ
would
facilit
determin
optim
time
stem
cell
transplant
acut
mi
presenc
circul
vsel
pb
tissu
injuri
indic
potenti
contribut
regener
injur
tissu
therefor
investig
regen
potenti
cell
anim
model
acut
mi
first
studi
dawn
et
al
investig
regen
efficaci
freshli
isol
bmderiv
lin
vsel
intramyocardi
transplant
mice
underw
ir
injuri
day
followup
vseltreat
mice
exhibit
improv
global
region
left
ventricular
lv
systol
function
echocardiographi
fig
attenu
myocyt
hypertrophi
surviv
tissu
histolog
echocardiographi
compar
vehicletr
control
contrast
transplant
lin
hspc
fail
confer
function
structur
benefit
vsel
isol
egfp
transgen
mice
use
transplant
could
track
fate
inject
cell
myocardium
observ
small
number
scatter
egfp
myocyt
capillari
infarct
region
border
zone
vseltreat
mice
zubasurma
et
al
subsequ
short
day
longterm
month
followup
studi
investig
repar
capac
vsel
process
ex
vivo
increas
number
cardiac
commit
frequenc
vsel
marrow
extrem
low
first
examin
whether
expand
cultur
without
loss
therapeut
efficaci
accordingli
egfp
vsel
isol
transgen
mice
propag
vitro
feeder
layer
increas
number
cell
transplant
expand
vsel
isol
flow
cytometri
base
egfp
fluoresc
fig
predifferenti
medium
contain
vegfa
combin
known
increas
cardiac
commit
stem
cell
day
mi
mice
treat
expand
predifferenti
vsel
exhibit
improv
global
region
lv
systol
function
echocardiographi
less
lv
hypertrophi
histolog
echocardiographi
compar
vehicletr
control
improv
cardiac
function
cell
therapi
report
transient
studi
next
experi
vsel
transplant
follow
cardiac
structur
function
period
coronari
occlus
reperfus
mice
receiv
intramyocardi
inject
vehicl
hspc
vsel
followup
vseltreat
mice
exhibit
persist
improv
lv
eject
fraction
ef
smaller
lv
endsystol
diamet
greater
diastol
infarct
wall
thick
result
studi
reveal
observ
benefici
effect
vsel
therapi
lv
function
anatomi
sustain
least
month
vsel
inject
importantli
tumor
format
observ
suffici
long
followup
consist
observ
previou
studi
small
number
scatter
egfp
cell
express
asarcomer
actin
von
willebrand
factor
note
myocardium
vseltreat
mice
three
independ
studi
discuss
establish
vsel
transplant
mi
associ
consist
signific
benefici
effect
myocardi
anatomi
global
function
although
vsel
transplant
result
isol
new
myocyt
capillari
infarct
region
number
small
account
observ
benefit
basi
observ
seem
like
cytokin
growth
factor
releas
differenti
vsel
may
directli
indirectli
respons
improv
cardiac
structurefunct
fig
alreadi
postul
paracrin
effect
may
predominantli
respons
benefit
observ
stemprogenitor
cell
transplant
heart
repair
releas
factor
often
exert
antiapoptot
action
salvag
injur
yet
aliv
cell
apoptosi
healthi
cell
neg
affect
product
inflamm
known
occur
damag
tissu
secret
factor
may
also
influenc
activ
endogen
progenitor
cell
alreadi
present
myocardi
tissu
lead
prolifer
differenti
whether
vsel
influenc
endogen
cardiac
precursor
analog
fashion
remain
investig
regard
recent
microarray
data
report
wojakowski
et
al
provid
import
insight
secretom
vsel
differ
stage
cardiac
differenti
among
sever
growth
factor
releas
differenti
vsel
particular
attent
focus
growth
factor
morphogen
signal
intermediari
well
known
stimul
cardiac
endotheli
differenti
primit
cell
includ
fgf
bmp
vegfa
angiopoietin
notch
sonic
hedgehog
postul
vsel
predifferenti
cardiomyogen
pathway
transplant
may
also
produc
similar
cytokin
growth
factor
follow
intramyocardi
inject
stimul
endogen
prolifer
differenti
cardiac
stemprogenitor
cell
csc
myocyt
endotheli
cell
presenc
csc
adult
heart
well
document
like
growth
factor
produc
transplant
vsel
activ
endogen
csc
lead
prolifer
differenti
incorpor
myocardium
result
function
improv
fig
although
safeti
efficaci
cell
therapi
cardiac
repair
establish
earli
clinic
trial
overal
progress
hinder
lack
ideal
cellular
substrat
approach
biolog
featur
vsel
includ
pluripot
natur
abil
secret
growth
factor
make
attract
celltherapi
strategi
human
promis
persist
benefit
lv
function
anatomi
conspicu
lack
tumor
format
vsel
transplant
anim
model
acut
mi
predict
success
similar
strategi
human
anticip
mechanist
studi
anim
model
soon
delin
safe
effect
approach
vsel
therapi
cardiac
repair
human
fig
potenti
mechan
underli
observ
structur
function
benefit
vsel
transplant
acut
myocardi
infarct
ex
vivo
prepar
vsel
transplant
includ
isol
vsel
fac
b
expans
feeder
layer
c
predifferenti
toward
cardiac
lineag
growthfactor
cocktail
b
base
find
postul
transplant
expand
predifferenti
vsel
may
lead
combin
event
vsel
may
directli
differenti
cardiomyocyt
smooth
muscl
cell
endotheli
cell
b
initi
protect
paracrin
respons
c
activ
endogen
cardiac
stemprogenitor
cell
csc
secret
growth
factor
event
may
respons
part
observ
benefit
